Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Annexin Pharmaceuticals via Annexin Incentive | 152,273 | net | 25 Oct 2021 | tx 3+152,273 |
| Nanologica AB (publ) | 94,838 | net | 07 Oct 2024 | tx 2+94,838 |
| IRLAB Therapeutics AB | 6,823 | net | 05 Oct 2021 | tx 3+6,823 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Oct 2024 | PURCHASE | Nanologica AB (publ) | 39,838 | 9.00 SEK | first after silence |
| 25 Oct 2021 | PURCHASE | Annexin Pharmaceuticals via Annexin Incentive | 75,000 | 1.25 SEK | |
| 05 Oct 2021 | PURCHASE | IRLAB Therapeutics AB | 2,573 | 43.35 SEK | first after silence |
| 14 Sept 2020 | PURCHASE | Nanologica AB (publ) | 55,000 | 0.70 SEK | deriv |
| 25 Feb 2020 | PURCHASE | Annexin Pharmaceuticals via Annexin Incentive | 50,000 | 1.26 SEK | |
| 25 Feb 2020 | PURCHASE | Annexin Pharmaceuticals via Annexin Incentive | 27,273 | 1.26 SEK | |
| 10 Sept 2019 | PURCHASE | IRLAB Therapeutics AB | 1,450 | 36.70 SEK | |
| 05 Sept 2019 | PURCHASE | IRLAB Therapeutics AB | 2,800 | 32.00 SEK |
2 purchases reported after at least 12 months of silence — most recent on 07 Oct 2024.